Skip to Main Content

Paper Details

Identification of a therapeutic target using molecular sequencing for treatment of recurrent uterine serous adenocarcinoma.
Gynecol Oncol Rep
5
2019
ERBB2, HER2, Uterine serous adenocarcinoma, endometrial cancer, neu, patient, trastuzumab, tumor, uterine serous adenocarcinoma, woman
Author NameAffiliation
Shannon M Glynn
Juan Miguel MosqueraEnglander Institute for Precision Medicine
Juan Miguel Mosquera
Juan Miguel MosqueraEnglander Institute for Precision Medicine
Juan Miguel Mosquera
Olivier ElementoEnglander Institute for Precision Medicine
Olivier ElementoEnglander Institute for Precision Medicine
Andrea SbonerEnglander Institute for Precision Medicine
Andrea SbonerEnglander Institute for Precision Medicine
Himisha Beltran
Himisha BeltranDana Farber Cancer Institute
Himisha BeltranEnglander Institute for Precision Medicine
Himisha Beltran
Himisha BeltranEnglander Institute for Precision Medicine
Himisha BeltranDana Farber Cancer Institute
Kevin Holcomb
  • 1 - 16

Datasets

Release 1.2